| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |